Thursday, June 11, 2020 9:13:01 AM
New interview and a new report from DJ_tar 14
https://www.proactiveinvestors.com/companies/news/921606/dyadic-and-frederick-national-laboratory-to-develop-c1-cell-lines-for-coronavirus-vaccine-candidates-921606.html
most optimistic I have ever head him (and that is saying a lot)
but can he get it over the goal line?????
https://www.proactiveinvestors.com/companies/news/921606/dyadic-and-frederick-national-laboratory-to-develop-c1-cell-lines-for-coronavirus-vaccine-candidates-921606.html
most optimistic I have ever head him (and that is saying a lot)
but can he get it over the goal line?????
Recent DYAI News
- Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 • GlobeNewswire Inc. • 05/21/2026 08:05:00 PM
- Sidoti Events, LLC's May Micro-Cap Virtual Conference • ACCESS Newswire • 05/20/2026 11:30:00 AM
- Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference • GlobeNewswire Inc. • 05/19/2026 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:11:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:10:46 PM
- Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/12/2026 08:30:27 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/11/2026 08:42:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/01/2026 09:00:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:00:46 PM
- Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2026 01:56:17 AM
- Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 03/25/2026 08:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:14:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:13:15 PM
- Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices • GlobeNewswire Inc. • 03/16/2026 11:20:00 AM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 • GlobeNewswire Inc. • 03/11/2026 08:10:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 10:04:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:02:34 PM
- Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) • GlobeNewswire Inc. • 03/04/2026 12:20:00 PM
- Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone • GlobeNewswire Inc. • 03/02/2026 12:20:00 PM
